Related Experiment Video
Updated: Jul 2, 2026
10:30
Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
Published on: January 25, 2017
8.8K
[Research advance of interleukin 24]
Mengyang Zhu1, Wen Chen2, Tao Zhang3
1Institute of Respiratory and Critical Care Medicine, Beijing Key Laboratory of Organ Transplantation and Immunology Regulatory, the 8th Medical Center of Chinese PLA General Hospital, Beijing 100091; Department of Immunology, School of Basic Medicine, Jiamusi University, Jiamusi 154007, China.
Summary
Interleukin 24 (IL-24) is a cytokine that inhibits tumor growth and aids healing. Understanding IL-24's mechanisms offers new therapeutic targets for inflammatory diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Interleukin 24 (IL-24) belongs to the IL-10 cytokine family.
- It is produced by lymphocytes and activated monocytes.
- IL-24 interacts with cellular components to activate key signaling pathways.
Purpose of the Study:
- To explore the physiological roles and molecular mechanisms of IL-24.
- To provide insights into IL-24's involvement in disease pathogenesis.
- To identify potential therapeutic strategies targeting IL-24.
Main Methods:
- Review of existing literature on IL-24.
- Analysis of IL-24's signaling pathways (JAK/STAT, p38 MAPK, ER stress).
- Examination of IL-24's functions in tumor suppression, wound healing, and cardiovascular health.
Main Results:
- IL-24 demonstrates anti-tumorigenic properties, inhibiting proliferation and invasion.
- IL-24 promotes wound healing and offers cardiovascular protection.
- Dysregulation of IL-24 is implicated in autoimmune and inflammatory conditions.
Conclusions:
- IL-24 plays a multifaceted role in physiological processes.
- Its signaling pathways are crucial for its diverse functions.
- IL-24 represents a promising therapeutic target for various diseases.
